Syncom Formulations (India) Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹13.47
Market cap
1,266 Cr
Stock P/E
15.9
P/B
3.05
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Standalone onlySept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales60 Cr124 Cr189 Cr263 Cr87 Cr189 Cr128 Cr149 Cr117 Cr122 Cr115 Cr135 Cr
Operating expenses (approx.)52 Cr105 Cr158 Cr220 Cr75 Cr161 Cr109 Cr124 Cr95 Cr98 Cr88 Cr99 Cr
EBITDA8 Cr19 Cr31 Cr43 Cr12 Cr28 Cr19 Cr25 Cr22 Cr24 Cr27 Cr37 Cr
OPM %13.9%15.2%16.2%16.4%13.5%14.9%14.7%16.6%18.7%19.4%23.2%27.0%
Other income2 Cr6 Cr10 Cr14 Cr1 Cr6 Cr4 Cr7 Cr6 Cr5 Cr6 Cr15 Cr
Interest1 Cr2 Cr3 Cr4 Cr0.39 Cr0.55 Cr0.20 Cr0.12 Cr0.25 Cr0.26 Cr0.26 Cr0.38 Cr
Depreciation1 Cr2 Cr3 Cr5 Cr1 Cr3 Cr1 Cr1 Cr1 Cr1 Cr1 Cr2 Cr
Profit before tax6 Cr15 Cr24 Cr34 Cr10 Cr25 Cr17 Cr23 Cr20 Cr22 Cr25 Cr34 Cr
Tax %28.1%25.1%25.1%25.4%24.4%24.9%24.7%24.1%22.4%24.7%24.6%25.3%
Net profit4 Cr11 Cr18 Cr25 Cr8 Cr19 Cr13 Cr18 Cr16 Cr17 Cr19 Cr25 Cr
EPS (₹)₹0.07₹0.15₹0.25₹0.34₹0.11₹0.27₹0.14₹0.16₹0.21₹0.18₹0.23₹0.27

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales224 Cr263 Cr465 Cr489 CrSign in for TTM
Operating expenses (approx.)205 Cr234 Cr393 Cr380 CrSign in for TTM
EBITDA20 Cr30 Cr72 Cr109 CrSign in for TTM
OPM %8.8%11.2%15.4%22.2%Sign in for TTM
Other income15 Cr14 Cr17 Cr31 CrSign in for TTM
Interest3 Cr4 Cr0.86 Cr1 CrSign in for TTM
Depreciation5 Cr5 Cr5 Cr7 CrSign in for TTM
Profit before tax27 Cr34 Cr66 Cr101 CrSign in for TTM
Tax %24.5%25.4%24.5%24.4%Sign in for TTM
Net profit20 Cr25 Cr49 Cr76 CrSign in for TTM
EPS (₹)₹0.24₹0.34₹0.57₹0.81Sign in for TTM
Dividend payout %14.1%0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital94 Cr94 Cr94 Cr94 Cr
Reserves162 Cr194 Cr246 Cr321 Cr
Borrowings83 Cr72 Cr5 Cr1 Cr
Other liabilities39 Cr44 Cr67 Cr117 Cr
Total liabilities330 Cr405 Cr413 Cr534 Cr
Fixed assets (net)43 Cr72 Cr78 Cr90 Cr
CWIP26 Cr0.0000 Cr0.0000 Cr0.0000 Cr
Investments64 Cr66 Cr93 Cr109 Cr
Other assets184 Cr279 Cr275 Cr337 Cr
Total assets330 Cr405 Cr413 Cr534 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity11 Cr-6 Cr23 Cr58 Cr
Cash from investing-45 Cr83 Cr-18 Cr-51 Cr
Cash from financing35 Cr-15 Cr-68 Cr-3 Cr
Net cash flow0.58 Cr63 Cr-63 Cr4 Cr
Free cash flow (OCF − Capex)-10 Cr-14 Cr13 Cr46 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %4.5%6.9%19.1%24.6%
ROE %0.0%8.8%0.0%0.0%
Debtor days123143——
Inventory days785954104
Days payable7567——
Cash conversion cycle12513554104
Debt / equity0.320.250.010.0036
Current ratio1.612.584.553.18
Net debt / EBITDA4.190.310.05-0.03

Compare with peers

Loading peers…